Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future

Patrick Rossignol1, Matthieu Legrand2, Mikhail Kosiborod3

  • 1Inserm, Centre d'Investigations Cliniques- 1433, and Inserm U1116, CHU Nancy, Université de Lorraine, Association Lorraine pour le Traitement de l'Insuffisance Rénale, F-CRIN INI-CRCT, Nancy, France.

Pharmacological Research
|October 4, 2016
PubMed

Insights

Emergency hyperkalemia treatment lacks strong evidence. New research is crucial to establish effective and safe emergency protocols for this common, potentially fatal electrolyte disorder.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Hyperkalemia is a frequent electrolyte disorder, particularly in patients with chronic kidney disease, diabetes mellitus, or heart failure.
  • It poses a risk of fatal cardiac dysrhythmias and is linked to increased mortality.
  • Current emergency treatment decisions rely heavily on subjective clinical judgment.

Purpose of the Study:

  • To evaluate existing knowledge on emergency hyperkalemia treatment.
  • To develop a treatment algorithm based on expert opinion and current evidence.
  • To identify knowledge gaps and prioritize future research in hyperkalemia management.

Main Methods:

  • A comprehensive literature search of PubMed was conducted up to August 4, 2015.
  • Included studies were consensus guidelines, reviews, randomized clinical trials, and observational studies.
  • The search was limited to English language publications.

Main Results:

  • Current hyperkalemia treatment strategies are based on limited evidence, anecdotal experience, and traditional practices.
  • The safety and real-world effectiveness of standard therapies are unproven.
  • Significant knowledge gaps exist regarding optimal patient characterization, potassium thresholds for arrhythmias, and intervention responses.

Conclusions:

  • Existing emergency treatments for severe hyperkalemia lack robust evidence and are inconsistently applied.
  • Further research, including randomized controlled trials, is essential to validate current practices and test new therapies.
  • Definitive trials are needed to optimize management strategies and improve patient outcomes.

Related Concept Videos

Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
447
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
631
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
578
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
569
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.2K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
459